Literature DB >> 8111071

Insulin-mimetic effects of vanadate in preventing the increase of P450IIIA and P450IA subfamily proteins in streptozotocin-diabetic rats.

A Verrecchia1, A Guaitani.   

Abstract

The insulin-mimetic effects of vanadate in preventing the increase in the level and activity of several P450 proteins in streptozotocin-diabetic rats were examined, in order to extend knowledge of the insulin-like actions of vanadate from glucose metabolism to P450-dependent metabolism. The diabetic state caused by the pancreatic beta cell toxin streptozotocin results, like the diabetes of genetic origin, in major alterations in the expression of P450 isozymes. We focused our attention on the P450III and P450I isoforms, known to be altered during the onset of diabetes. We found an increase in P450IIIA1-linked erythromycin demethylase activity (to about double the control level) and in the relative levels of P450III and P450I isozymes after 2 weeks of uncontrolled diabetes. These parameters were not different from control values in rats given vanadate in drinking water for 2 weeks after streptozotocin administration or in insulin-treated rats. In summary, vanadate appears to exert insulin-mimetic actions on the P450III and P450I family proteins that have a key role in cytochrome P450-dependent metabolism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8111071     DOI: 10.1007/bf00572855

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  25 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Hepatic drug metabolism is increased in poorly controlled insulin-dependent diabetes mellitus.

Authors:  S Goldstein; A Simpson; P Saenger
Journal:  Acta Endocrinol (Copenh)       Date:  1990-11

Review 3.  Substrate specificities and functions of the P450 cytochromes.

Authors:  M R Juchau
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

4.  Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats.

Authors:  S M Brichard; W Okitolonda; J C Henquin
Journal:  Endocrinology       Date:  1988-10       Impact factor: 4.736

5.  Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver.

Authors:  D L Cinti; P Moldeus; J B Schenkman
Journal:  Biochem Pharmacol       Date:  1972-12-15       Impact factor: 5.858

6.  Growth hormone secretory dynamics in streptozotocin diabetes: evidence of a role for endogenous circulating somatostatin.

Authors:  G S Tannenbaum
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

7.  Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes.

Authors:  C R Barnett; G G Gibson; C R Wolf; P R Flatt; C Ioannides
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

8.  Identification of an inducible form of cytochrome P-450 in human liver.

Authors:  P B Watkins; S A Wrighton; P Maurel; E G Schuetz; G Mendez-Picon; G A Parker; P S Guzelian
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes.

Authors:  P Bertault-Peres; C Bonfils; G Fabre; S Just; J P Cano; P Maurel
Journal:  Drug Metab Dispos       Date:  1987 May-Jun       Impact factor: 3.922

Review 10.  The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?

Authors:  S M Brichard; J Lederer; J C Henquin
Journal:  Diabete Metab       Date:  1991 Sep-Oct
View more
  3 in total

1.  Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.

Authors:  Yu C Kim; Joo H Lee; So H Kim; Myung G Lee
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

2.  Modulation of CYP3a expression and activity in mice models of type 1 and type 2 diabetes.

Authors:  Dany Patoine; Michaël Petit; Sylvie Pilote; Frédéric Picard; Benoit Drolet; Chantale Simard
Journal:  Pharmacol Res Perspect       Date:  2014-09-01

Review 3.  Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity.

Authors:  Lucy Darakjian; Malavika Deodhar; Jacques Turgeon; Veronique Michaud
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.